These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19125553)

  • 1. Prior authorization and clopidogrel use--the truth lies in the details.
    Jackson MA; Fairman KA; Curtiss FR
    J Manag Care Pharm; 2009; 15(1):71-7. PubMed ID: 19125553
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacy benefit spending poised to increase for antithrombotic drug therapy -- prasugrel versus clopidogrel.
    Curtiss FR; Fairman KA
    J Manag Care Pharm; 2009 Jun; 15(5):414-6. PubMed ID: 19496638
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular outcomes after a change in prescription policy for clopidogrel.
    Jackevicius CA; Tu JV; Demers V; Melo M; Cox J; Rinfret S; Kalavrouziotis D; Johansen H; Behlouli H; Newman A; Pilote L
    N Engl J Med; 2008 Oct; 359(17):1802-10. PubMed ID: 18946065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and Plavix: what every clinical nurse specialist should know now.
    O'Malley P
    Clin Nurse Spec; 2007; 21(1):13-5. PubMed ID: 17213734
    [No Abstract]   [Full Text] [Related]  

  • 5. Clopidogrel in acute coronary syndromes: can the cost effectiveness improve?
    Sánchez-Delgado E
    Circulation; 2003 Aug; 108(8):e56; author reply e56. PubMed ID: 12939246
    [No Abstract]   [Full Text] [Related]  

  • 6. Generic clopidogrel: time to substitute?
    Doll J; Zeitler E; Becker R
    JAMA; 2013 Jul; 310(2):145-6. PubMed ID: 23839745
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of clopidogrel in cardiovascular diseases].
    Gurbel PA; Tantry US
    Pol Arch Med Wewn; 2007; 117(5-6):207-9. PubMed ID: 18030868
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Akinlade BK
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12571267
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of proton pump inhibitors in patients receiving clopidogrel: meta-analysis versus clinical practice.
    van Oijen MG; Siersema PD
    Drug Saf; 2011 Feb; 34(2):173; author reply 174. PubMed ID: 21247223
    [No Abstract]   [Full Text] [Related]  

  • 10. Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
    Barski PR
    N Engl J Med; 2005 Apr; 352(16):1716-8; author reply 1716-8. PubMed ID: 15846857
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Ramsey SD
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572583
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic effects of extended clopidogrel therapy--a word of caution.
    Eriksson P
    J Am Coll Cardiol; 2005 Oct; 46(7):1376; author reply 1376-7. PubMed ID: 16198862
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Yaes RJ
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572584
    [No Abstract]   [Full Text] [Related]  

  • 14. Clopidogrel pharmacogenetics: from evidence to implementation.
    Cavallari LH; Duarte JD
    Future Cardiol; 2016 Sep; 12(5):511-4. PubMed ID: 27539287
    [No Abstract]   [Full Text] [Related]  

  • 15. Using clopidogrel bisulfate: a new antiplatelet drug.
    Pfister SM
    Nurse Pract; 1999 Sep; 24(9):100-1, 105-8, 110. PubMed ID: 10507077
    [No Abstract]   [Full Text] [Related]  

  • 16. Restrictive access to clopidogrel and mortality following coronary stent implantation.
    Sheehy O; LeLorier J; Rinfret S
    CMAJ; 2008 Feb; 178(4):413-20. PubMed ID: 18268267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Armstrong EC
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572582
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clopidogrel--an expensive thrombocyte inhibitor with a small marginal benefit].
    Asplund K
    Lakartidningen; 2000 Mar; 97(11):1294-6. PubMed ID: 10771550
    [No Abstract]   [Full Text] [Related]  

  • 19. Clopidogrel in cardiovascular disorders.
    Kulkarni RA
    J Postgrad Med; 2000; 46(4):312-3. PubMed ID: 11435665
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    de Lemos JA; McGuire DK
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.